Approximately 30% of patients with advanced, metastatic differentiated thyroid cancer have
radioiodine-refractory disease, based on decreased expression of the sodium iodide …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Targeted therapy pinpointing specific alteration in cancer cells has gained an important role
in the treatment of cancer. Compounds that re-induce thyroid-specific functions could be …

[131 I] meta-iodobenzylguanidine ([131 I] MIBG) is the most commonly used treatment for
metastatic pheochromocytoma and paraganglioma. It enters the chromaffin cells via the …

The concept of individualized therapy is rapidly gaining recognition in the management of
patients with differentiated thyroid cancer (DTC). This Review provides an overview of the …

Background: Nuclear receptors (NRs) play a key role in endocrine signaling and metabolism
and are important therapeutic targets in a number of hormone-dependent malignancies …

The thyroid hormones are essential for the development and maturation of the central
nervous system, lungs, and skeletal system, and for intermediary metabolism in virtually all …

Le cancer papillaire de la thyroïde (CPT) est la tumeur endocrine la plus fréquente. Des
anomalies moléculaires activant la voie des MAPK (Mitogen-Activated Protein Kinases) sont …

Résumé Les nouvelles recommandations 2014 de l'American Thyroid Association sur la
prise en charge des cancers thyroïdiens de souche vésiculaire ont été présentées au …

This chapter focuses on the relatively narrow definition of radiovirotherapy as “the use of
viral vectors engineered to express genes that drive uptake of radioisotopes into cancer …